Megan Ranney
A Prescription for Rebuilding Trust in the FDA
The FDA should recommit to transparent, evidence-based decision-making, apply its standards consistently, and modernize its regulatory systems, argue Yale SOM’s Jeffrey Sonnenfeld, Megan Ranney and Sten Vermund of the Yale School of Public Health, and Harvard neurologist Patricia Greenstein, with co-author Steven Tian.